Page last updated: 2024-08-26

desethylamiodarone and Carcinoma, Hepatocellular

desethylamiodarone has been researched along with Carcinoma, Hepatocellular in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bakker, O; Hudig, F; Meijssen, S; Wiersinga, WM1

Other Studies

1 other study(ies) available for desethylamiodarone and Carcinoma, Hepatocellular

ArticleYear
Effects of triiodothyronine and amiodarone on the promoter of the human LDL receptor gene.
    Biochemical and biophysical research communications, 1998, Aug-19, Volume: 249, Issue:2

    Topics: Amiodarone; Anti-Arrhythmia Agents; Carcinoma, Hepatocellular; Gene Expression; Humans; Liver Neoplasms; Promoter Regions, Genetic; Receptors, LDL; Receptors, Thyroid Hormone; Transfection; Triiodothyronine; Tumor Cells, Cultured

1998